5 Most Shorted Stocks That Are Loved By Analysts

3. BioVie Inc. (NASDAQ:BIVI)

Short Interest Percentage: 9.51%

Average Share Price Target: $11.5

Share Price Upside: 241%

BioVie Inc. (NASDAQ:BIVI) is a biotechnology company developing treatments for Alzheimer’s disease, Parkinson’s disease, and other ailments. The firm’s second quarter earnings marked a turnaround of sorts, as it was the first quarter after the last three in which the firm had beaten analyst EPS estimates.

Insider Monkey took a look at 910 hedge fund portfolios and discovered five BioVie Inc. (NASDAQ:BIVI) investors during 2023’s second quarter. Neil Shahrestani’s Ikarian Capital is the company’s largest investor since it owns $1.9 million worth of shares.

Follow Biovie Inc.